The lesser of two adverse reactions

Joint Commission Journal on Quality and Patient Safety

Volumn 36, Issue 1, 2010, Pages 22-27

  Chakraborti, Chayan ^a,b   Egan, John ^a,c  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ONDANSETRON; PROMETHAZINE;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; FEMALE; HEART BLOCK; HOSPITAL MANAGEMENT; HUMAN; METHODOLOGY; MIDDLE AGED;

ANTIEMETICS; FEMALE; HEART BLOCK; HOSPITAL ADMINISTRATION; HUMANS; MIDDLE AGED; ONDANSETRON; PROMETHAZINE;

EID: 77449153422     PISSN: 15537250     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1553-7250(10)36004-1     Document Type: Article

References (23)

1. Institute of Medicine: To Err Is Human: Building a Safer Health System: Washington, DC: National Academy Press, 2000.
2. Barach P. Small S.D. Reporting and preventing medical mishaps: Lessons from non-medical near miss reporting systems British Medical Journal 2000 320 7237 759-763 2. Barach P., Small S.D.: Reporting and preventing medical mishaps: Lessons from non-medical near miss reporting systems. BMJ 320: 759-763, Mar. 18, 2000. (Pubitemid 30179427)
3. Cook R.I. Render M. Woods D.D. Gaps in the continuity of care and progress on patient safety British Medical Journal 2000 320 7237 791-794 3. Cook R.I., Render M., Woods D.D.: Gaps in the continuity of care and progress on patient safety. BMJ 320: 791-794, Mar. 18, 2000. (Pubitemid 30179436)
4. Institute for Safe Medication Practices (ISMP): Action needed to prevent serious tissue injury with IV promethazine. ISMP Medication Safety Alert! Acute Care, Aug. 10, 2006. http://www.ismp.org/Newsletters/acutecare/ articles/20060810.asp (last accessed Nov. 19, 2009).
5. Institute for Safe Medication Practices (ISMP): Promediazine conundrum: IV can hurt more than IM injection! ISMP Medication Safety Alert! Acute sCare, Nov. 2, 2006. http://www.ismp.org/Newsletters/acutecare/articles/ 20061102.asp (last accessed Nov. 19, 2009.
6. U.S. Food and Drug Administration: Information for Healthcare Professionals-Promethazine (Marketed as Phenergan and Generic Products). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor PatientsandProviders/ucm 126465.htm (last accessed Nov. 19, 2009).
7. Mostafavi H., Samimi M.: Accidental intra-arterial injection of promethazine HCl during general anesthesia: Report of a case. Anesthesiology 35: 645-646, Jun. 1971.
8. Baguley W.A., et al.: Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide. Anesth Analg 84: 1380-1381, Jun. 1997.
9. Costall B., Naylor R.J.: 5-HT3 receptora. Curr Drug Targets CNS Neurol Disord3(1): 27-37, Feb. 2004.
10. Charbit B. Albaladejo P. Funck-Brentano C. Legrand M. Samain E. Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron Anesthesiology 2005 102 6 1094-1100 DOI 10.1097/00000542-200506000-00006 10. Charbit B., et al.: Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 102: 1094-1100, Jun. 2005. (Pubitemid 40745825)
11. Miller D.R.: Arrhythniogenic potential of antiemetics: Perspectives on risk-benefits. Can J Anaesth 50: 215-220, Mar. 2003.
12. Moore T.J., Cohen M.R., Furberg C.D.: Strong Safety Signal Seen for New Varenicline Risks. Institute for Safe Medication Practices. http://www.ismp.org/ docs/vareniclineStudy.asp (last accessed Nov. 19, 2009).
13. Curfman G.D., Morrissey S., Drazen J.M.: Why doctors should worry about preemption. N Engl J Med 359: 1-3, Jul. 3, 2008.
14. Nolan T.W.: System changes to improve patient safety. BMJ 320: 771-773, Mar. 18, 2000.
15. Kasinath N.S. Malak O. Tetzlaff J.E. Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: A case report Canadian Journal of Anesthesia 2003 50 3 229-231 15. Kasinath N.S., Malak O., Tetzlaff J.: Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: A case report. Can J Anaesth 50: 229-231, Mar. 2003. (Pubitemid 36442854)
16. Webb G. A., Lampert N.: Accidental arterial injections. Am J Obstet Gynecol 101: 365-371, Jun. 1, 1968.
17. Hager D.L., Wilson J.N.: Gangrene of the hand following intra-arterial injection. Anesth Analg 47: 423-427, Jul.-Aug. 1968.
18. Faucher L., Marcoux D.: What syndrome is this? Nicolau syndrome. Pediatr Dermatol 12: 187-190, Jun. 1995.
19. Malesker M.A., et al.: Extravasation of IV promethazine. Am J Health Syst Pharm 56: 1742-1743, Sep. 1, 1999.
20. Paparella S.: The dangers of intravenous promethazine administration. J Emerg Nurs 33: 53-56, Feb. 2007.
21. Strausser R.: Questions and answers from the FIX: IV promethazine and tissue ulceration. Hasp Pharm 37: 28-33, Jan. 2002.
22. Sen S. Chini E.N. Brown M.J. Complications after unintentional intra-arterial injection of drugs: Risks, outcomes, and management strategies Mayo Clinic Proceedings 2005 80 6 783-795 22. Sen S., Chini E.N., Brown M.J.: Complications after unintentional intraarterial injection of drugs: Risks, outcomes, and management strategies. Mayo Clin Proc 80: 783-795, Jun. 2005. (Pubitemid 40770366)
23. Keene J.R., et al.: Accidental intra-arterial injection: A case report, new treatment modalities, and a review of the literature. J Oral Maxillofac Surg 64: 965-968, Jun. 2006.